| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
1,095,971,000 |
| Market
Cap: |
14.26(B) |
| Last
Volume: |
8,982,070 |
Avg
Vol: |
10,607,441 |
| 52
Week Range: |
$7.2 - $14.43 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ-100 |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Teva Pharmaceutical Industries is a pharmaceutical company. Co. operates through three segments: North America, which includes the U.S. and Canada; Europe, which includes the European Union and certain other European countries; and International Markets, which includes all countries in which Co. operates other than those in Co.'s North America and Europe segments. Co.'s products include: AUSTEDO; AJOVY (anti calcitonin gene-related peptide); COPAXONE; BENDEKA and TREANDA; ProAir HFA; ProAir RespiClick; QVAR; QVAR RediHaler; ProAir Digihaler; ArmonAir Digihaler; AirDuo Digihaler; BRALTUS®; CINQAIR/CINQAERO; and AirDuo RespiClick.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
677,343 |
677,343 |
767,191 |
1,433,490 |
| Total Sell Value |
$8,974,605 |
$8,974,605 |
$9,773,842 |
$16,030,825 |
| Total People Sold |
8 |
8 |
8 |
11 |
| Total Sell Transactions |
14 |
14 |
17 |
32 |
| End Date |
2024-01-25 |
2023-10-24 |
2023-04-25 |
2022-04-25 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Kalif Eliyahu Sharon |
EVP, Chief Financial Officer |
• – – |
2024-03-06 |
4 |
AS |
$13.52 |
$1,048,119 |
D/D |
(77,550) |
203,691 |
|
-5% |
|
| Conway Vikki L |
See Remarks |
• – – |
2024-03-05 |
4 |
AS |
$13.52 |
$19,286 |
D/D |
(1,427) |
15,219 |
|
-5% |
|
| Conway Vikki L |
See Remarks |
• – – |
2024-03-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,954 |
16,646 |
|
- |
|
| Weiss Amir |
Chief Accounting Officer |
• – – |
2024-03-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,564 |
33,314 |
|
- |
|
| Kalif Eliyahu Sharon |
EVP, Chief Financial Officer |
• – – |
2024-03-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
73,707 |
281,241 |
|
- |
|
| Daniell Richard |
Exec. VP, European Commercial |
• – – |
2024-03-05 |
4 |
AS |
$13.52 |
$657,240 |
D/D |
(48,629) |
98,943 |
|
-5% |
|
| Daniell Richard |
Exec. VP, European Commercial |
• – – |
2024-03-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
77,802 |
124,996 |
|
- |
|
| Sabag Mark |
EVP, International Markets |
• – – |
2024-03-05 |
4 |
S |
$13.52 |
$1,352,090 |
D/D |
(100,000) |
382,590 |
|
4% |
|
| Sabag Mark |
EVP, International Markets |
• – – |
2024-03-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
81,897 |
482,590 |
|
- |
|
| Drape Eric |
Executive VP Global Operations |
• – – |
2024-03-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
77,802 |
145,915 |
|
- |
|
| Hughes Eric A |
See Remarks |
• – – |
2024-03-04 |
4 |
AS |
$13.34 |
$107,299 |
D/D |
(8,045) |
16,855 |
|
-4% |
|
| Weiss Amir |
Chief Accounting Officer |
• – – |
2024-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,676 |
29,750 |
|
- |
|
| Conway Vikki L |
See Remarks |
• – – |
2024-03-04 |
4 |
AS |
$13.37 |
$47,234 |
D/D |
(3,532) |
11,692 |
|
-4% |
|
| Conway Vikki L |
See Remarks |
• – – |
2024-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,117 |
13,734 |
|
- |
|
| Drape Eric |
Executive VP Global Operations |
• – – |
2024-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
33,512 |
77,928 |
|
- |
|
| Daniell Richard |
Exec. VP, European Commercial |
• – – |
2024-03-04 |
4 |
AS |
$13.34 |
$1,277,207 |
D/D |
(95,762) |
69,770 |
|
-4% |
|
| Daniell Richard |
Exec. VP, European Commercial |
• – – |
2024-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
33,512 |
103,282 |
|
- |
|
| Kalif Eliyahu Sharon |
EVP, Chief Financial Officer |
• – – |
2024-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
33,512 |
207,534 |
|
- |
|
| Sabag Mark |
EVP, International Markets |
• – – |
2024-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
33,512 |
400,693 |
|
- |
|
| Francis Richard D |
President and CEO |
• – – |
2024-03-04 |
4 |
AS |
$13.34 |
$414,270 |
D/D |
(31,061) |
123,295 |
|
-4% |
|
| Hughes Eric A |
See Remarks |
• – – |
2024-03-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
24,900 |
24,900 |
|
- |
|
| Weiss Amir |
Chief Accounting Officer |
• – – |
2024-03-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,179 |
19,074 |
|
- |
|
| Conway Vikki L |
See Remarks |
• – – |
2024-03-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,179 |
8,107 |
|
- |
|
| Drape Eric |
Executive VP Global Operations |
• – – |
2024-03-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
24,900 |
44,416 |
|
- |
|
| Daniell Richard |
Exec. VP, European Commercial |
• – – |
2024-03-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
62,250 |
132,020 |
|
- |
|
521 Records found
|
|
Page 1 of 21 |
|
|
